Literature DB >> 12411467

Endoglin upregulation during experimental renal interstitial fibrosis in mice.

Ana Rodríguez-Peña1, Nélida Eleno, Anette Düwell, Miguel Arévalo, Fernando Pérez-Barriocanal, Olga Flores, Neil Docherty, Carmelo Bernabeu, Michelle Letarte, José M López-Novoa.   

Abstract

The goal of the present study was to evaluate the role of endoglin, a transforming growth factor-beta1 (TGF-beta1) accessory receptor, in the pathogenesis of renal fibrosis. This was achieved by testing a model of tubulo-interstitial fibrosis induced by unilateral ureteral obstruction in endoglin heterozygous (Eng(+/-)) mice. Northern and Western blot analysis revealed that endoglin expression in kidneys of these mice was significantly reduced compared with Eng(+/+) littermates. Pronounced interstitial fibrosis induced by ureteral obstruction was confirmed histologically by Masson's trichromic staining and by increased immunostaining for fibronectin and laminin without significant differences between Eng(+/-) and Eng(+/+) mice. Ureteral obstruction induced significant increases in alpha2(I) and alpha1(IV) collagen, fibronectin, and TGF-beta1 mRNA levels, as well as in total kidney collagen but changes were similar in Eng(+/-) and Eng(+/+) mouse kidneys. Ureteral obstruction also induced a 2-fold increase in endoglin mRNA levels in both Eng(+/+) mice and Eng(+/-) mice, which was confirmed by Western blot analysis. Thus, the present study provides clear evidence that endoglin is upregulated in the kidneys of mice with interstitial fibrosis induced by unilateral ureteral ligation. However, Eng(+/-) mice do not show any changes in the severity of renal disease induced in this model when compared with normal mice, suggesting that the absolute level of endoglin is not critical for the effects of TGF-beta1 in the renal fibrosis process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411467     DOI: 10.1161/01.hyp.0000037429.73954.27

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

Review 1.  The Role of Endoglin in Myocardial Fibrosis.

Authors:  Kou-Gi Shyu
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

Review 2.  TGF-β: the master regulator of fibrosis.

Authors:  Xiao-Ming Meng; David J Nikolic-Paterson; Hui Yao Lan
Journal:  Nat Rev Nephrol       Date:  2016-04-25       Impact factor: 28.314

3.  Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.

Authors:  Erin Morris; Izabela Chrobak; Andreea Bujor; Faye Hant; Christine Mummery; Peter Ten Dijke; Maria Trojanowska
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

4.  Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure.

Authors:  Navin K Kapur; Kevin S Heffernan; Adil A Yunis; Peter Parpos; Michael S Kiernan; Nikhil A Sahasrabudhe; Carey D Kimmelstiel; David A Kass; Richard H Karas; Michael E Mendelsohn
Journal:  Am J Cardiol       Date:  2010-12-15       Impact factor: 2.778

Review 5.  Role of endoglin in fibrosis and scleroderma.

Authors:  Janita A Maring; Maria Trojanowska; Peter ten Dijke
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

6.  Endoglin in liver fibrosis.

Authors:  Kenneth W Finnson; Anie Philip
Journal:  J Cell Commun Signal       Date:  2011-12-01       Impact factor: 5.782

Review 7.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

Review 8.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

9.  Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis.

Authors:  Maria L Mancini; Aleksandra Terzic; Barbara A Conley; Leif H Oxburgh; Teodora Nicola; Calvin P H Vary
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

10.  Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes.

Authors:  Patricia Alvarez-Muñoz; Michael Mauer; Youngki Kim; Stephen S Rich; Michael E Miller; Gregory B Russell; José M Lopez-Novoa; M Luiza Caramori
Journal:  J Diabetes Complications       Date:  2009-04-23       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.